Page last updated: 2024-10-27

flurbiprofen and Genetic Diseases, Inborn

flurbiprofen has been researched along with Genetic Diseases, Inborn in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Genetic Diseases, Inborn: Diseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent's genome or they may be acquired in utero.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qiang, L1
Guan, Y1
Li, X1
Liu, L1
Mu, Y1
Sugano, A1
Takaoka, Y1
Sakaeda, T1
Imbimbo, BP1
Yamamura, KI1
Jin, S1
Li, Z1

Trials

1 trial available for flurbiprofen and Genetic Diseases, Inborn

ArticleYear
CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects.
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2017, Volume: 24, Issue:1

    Topics: Amyloidosis; Cyclopropanes; Flurbiprofen; Genetic Diseases, Inborn; Humans; Prealbumin; Thyroxine

2017